Labcorp Oncology Engager | Digital Event

Labcorp_Oncology_ CROPPED

Success & Failure in Oncology Drug Development: Insights on Achieving Accelerated Development Timelines in the Era of a Pandemic

Tuesday February 15, 2022 | 11:00am ET | 8:00am PT

The Labcorp Oncology Engager will cover:

Success & Failure in Oncology Drug Development:
Insights on Achieving Accelerated Development Timelines in the Era of a Pandemic

 

Welcome to the Labcorp Oncology Engager, an exclusive online event providing leaders in biotechs with the opportunity to explore strategies that have been successful in responding to cancer patient needs and achieving accelerated oncology drug development.

Join this Engager to analyze decentralized clinical trial (DCT) technique integration and the benefits such techniques bring to achieving an accelerated, patient-centric trial design.

KEY TAKEAWAYS

  • Understand how critical careful orchestration of regulatory affairs, biomarker development/use, trial design and decentralized technique integration is in reducing timelines for oncology drug development
  • Delve into the benefits of a pragmatic analysis of decentralized trial technique integration and how it can help achieving an accelerated, patient-centric trial design
  • Familiarize yourself with how Labcorp Oncology accelerates patient, physician and site recruitment for oncology studies, and how these techniques are critical to overall timeline acceleration

This is an exclusive, limited-attendance event for Heads of Development, CMOs, Clinical Operations Leaders and COOs from biotechs who have recently entered early clinical development in the Oncology or Immuno-Oncology space. If you are looking to get an overview of how to accelerate drug development and ultimately, improve outcomes for cancer patients, then this is the event for you.

EXPERT SPEAKERS

ABOUT LABCORP ONCOLOGY

Labcorp Oncology believes in harnessing science to improve health and the lives of people with cancer. And so we work day and night, around the world, to support the delivery of more treatment options — whether you're a healthcare provider, pharmaceutical company, hospital, medical researcher or patient. Learn about Labcorp Drug Development and Labcorp Oncology at www.drugdevelopment.labcorp.com and www.oncology.labcorp.com

APPLY TO ATTEND